Menu
Recruiting NCT07402681

Evaluating Symptom Variations and Observing Longitudinal Individual Change Effects in TF-CBT

Observational Post-traumatic Stress Symptoms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Trauma-focused Cognitive Behavioral Therapy for Children and Adolescents.
Who it may be relevant to
Registry conditions: Post-traumatic Stress Symptoms. Basic parameters: 12 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this observational study is to learn about the level of change in post-traumatic stress symptoms in adolescents with traumatic experiences over the course of trauma-focused cognitive behavioral therapy for children and adolescents according to Cohen, Manarinno, \& Deblinger (2017).

Interventions

  • Other Trauma-focused Cognitive Behavioral Therapy for Children and Adolescents
    TF-CBT is a child and family-focused, component-based trauma-focused intervention that aims to address post-traumatic stress symptoms and other trauma-related difficulties (e.g., anxiety, depression) associated with traumatic events.

Primary outcome measures

  • Short, semi-individually-tailored questionnaire - so-called Idiosyncratic Assessment (IA) - assessing the six ICD-11 PTSS plus six individually selected PTSS that are most distressing to the patient. [Time frame: The IA will be assessed every two days four weeks before the start of TF-CBT treatment as well as every two days over the course of TF-CBT treatment; up to 1year]
Secondary outcome measures (8)
  • International Depression Questionnaire (IDQ) [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up; up to 1.5 years]
  • International Anxiety Questionnaire (IAQ) [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up; up to 1.5 years]
  • Child Post-Traumatic Cognitions Inventory (CPTCI) [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up, up to 1.5 years]
  • Child and Adolescent Trauma Screen 2 (CATS-2) [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up, up to 1.5 years]
  • Functioning scale of the Ohio Scales Youth Scales [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up, up to 1.5 years]
  • Inventory for the assessment of Negative Effects of Psychotherapy for children and adolescents [Time frame: Post-treatment, up to 1 year]
  • Parental Acceptance Rejection Questionnaire (PARQ) [Time frame: Baseline, pre-treatment, after TF-CBT stabilization and skills phase, after TF-CBT trauma narrative treatment phase, after TF-CBT cognitive restructuring-treatment phase, post-treatment, three-month follow-up, up to 1.5 years]
  • Session Rating Scale (SRS) [Time frame: After every TF-CBT treatment session, up to 1 year]

Eligibility criteria

Participants will be included if:

  • they are between 12 and 18 years of age;
  • they have been exposed to at least one or more traumatic event(s) according to the DSM-5 A criteria after the age of 3 years and dating back at least 1 months (with regard to the ability of patients to remember the event(s) and to the high spontaneous remissions of PTSS in the first month after a traumatic event);
  • they exhibit high severity of DSM-5 PTSS as indicated by a total symptom score of ≥25 assessed with the Child and Adolescent Trauma Screen 2 (CATS-2);
  • a nonoffending adult caregiver is available for the treatment and willing to participate in weekly treatment sessions (the inclusion of a caregiver is integral to the TF-CBT treatment model);
  • they are willing and able to attend weekly treatment sessions;
  • if their living circumstances are safe and stable to minimize the risk of re-traumatization during the project;
  • they and their caregiver have sufficient command of the German language (i.e., to participate in assessment \[read\] and treatment\[converse\]);
  • they and their caregivers possess a smartphone.
  • they and their caregiver provided written informed consent.

Participants will not be included if:

  • they exhibit acute suicidal behavior or have suicidal ideations requiring immediate hospitalization;
  • they have a documented developmental disorder (i.e., autism spectrum disorder) or current psychosis based on adolescent- and caregiver-report and clinical assessment;
  • they exhibit severe substance misuse based on clinical assessment;
  • take part in concurrent psychotherapy during TF-CBT;
  • exhibit severe intellectual disability based on clinical assessment.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Switzerland · 1 center
  • University Children's Hospital Zurich — Zurich

Identifiers

NCT: NCT07402681 · 2024-00903

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗